Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jun. 29, 2013	Jun. 30, 2012
Operating activities:
Net income	$ 3,820,330	$ 3,693,420
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	954,345	899,775
Provision for losses on accounts receivable	49,784	(27,000)
Gain on sale and disposal of property and equipment	(916)
Increase in cash value of life insurance	(126,051)	(148,302)
Deferred compensation	(44,879)	(40,503)
Stock compensation expense	27,582	54,198
Changes in operating assets and liabilities:
Accounts receivable	(2,029,044)	(967,016)
Inventories	2,716,959	2,241,060
Prepaid expenses and other assets	(452,764)	288,275
Accounts payable and accrued expenses	517,142	(395,736)
Net cash provided by operating activities	5,432,488	5,598,171
Investing activities:
Acquisition of M.C. Healthcare		(8,251,831)
Proceeds from sale of securities available for sale		4,000,000
Purchases of property and equipment	(427,654)	(627,645)
Proceeds from sale of property and equipment	7,850
Payments for other assets	(87,376)	(88,917)
Net cash used for investing activities	(507,180)	(4,968,393)
Financing activities:
Proceeds of long-term debt		9,300,000
Repayment of long-term debt		(8,300,000)
Dividends paid	(4,026,044)	(993,518)
Common stock issued upon exercise of options	147,665	68,946
Net cash (used for) provided by financing activities	(3,878,379)	75,428
Effect of exchange rates on cash	(114,164)	(40,212)
Increase in cash and cash equivalents	932,765	664,994
Cash and cash equivalents at beginning of period	2,665,302	2,124,406
Cash and cash equivalents at end of period	$ 3,598,067	$ 2,789,400